文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

晚期慢性肾病患者透析启动时机对降低死亡率和心血管事件的影响:全国队列研究

Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study.
PubMed 文献 · BMJ · 2021-11-29
一句话结论瑞典全国队列显示,eGFR15-16启动透析较eGFR6-7启动五年绝对死亡风险低5.1%,但需提前约四年开始透析。

该全国观察性队列纳入2007年1月1日至2016年12月31日期间基线eGFR 10-20 mL/min/1.73 m2的10290例晚期慢性肾病患者,采用克隆、删失和加权方法模拟临床试验严格设计,以动态边际结构模型估计15种透析启动策略(eGFR 4-19 mL/min/1.73 m2,每1 mL/min/1.73 m2递增)的五年全因死亡和主要不良心血管事件调整风险比与绝对风险,以eGFR6-7为参照。死亡风险呈抛物线关系,eGFR15-16启动风险最低:较eGFR6-7启动,五年绝对死亡风险低5.1%(95%CI 2.5%至6.9%),主要不良心血管事件风险低2.9%(95%CI 0.2%至5.5%),对应HR分别为0.89(95%CI 0.87至0.92)和0.94(95%CI 0.91至0.98)。5.1%绝对风险差对应五年随访平均推迟死亡1.6个月,但透析需提前四年开始。作者认为对多数患者而言,这种降低可能抵不过透析时间显著延长的负担。

要点

  • 在10290例晚期CKD患者中,eGFR15-16启动透析较eGFR6-7启动五年绝对死亡风险低5.1%(95%CI 2.5%至6.9%),HR 0.89(95%CI 0.87至0.92)。
  • eGFR15-16启动较eGFR6-7启动主要不良心血管事件风险低2.9%(95%CI 0.2%至5.5%),HR 0.94(95%CI 0.91至0.98)。
  • 5.1%绝对死亡风险差对应五年随访平均推迟死亡1.6个月,但透析需提前四年开始。
  • 模拟IDEAL试验意图策略(eGFR10-14 vs eGFR5-7)全因死亡HR 0.96(95%CI 0.94至0.99),模拟IDEAL实际达到eGFR(eGFR7-10 vs eGFR5-7)HR 0.97(95%CI 0.94至1.00),与随机IDEAL试验结果一致。
  • 作者认为对多数患者,极早启动透析带来的死亡和心血管事件小幅降低可能抵不过透析时间显著延长的负担。

适用人群与场景

  • 基线eGFR在10至20 mL/min/1.73 m2之间、2007年1月1日至2016年12月31日期间纳入瑞典国家肾脏登记、转诊至肾脏科医生的晚期慢性肾病患者,随访至2017年6月1日。

处置流程与药物剂量

  • 研究评估15种透析启动策略,eGFR值在4至19 mL/min/1.73 m2之间、以1 mL/min/1.73 m2递增,以eGFR6-7 mL/min/1.73 m2为参照。
  • eGFR15-16启动透析较eGFR6-7启动与五年绝对死亡风险低5.1%(95%CI 2.5%至6.9%)和主要不良心血管事件风险低2.9%(95%CI 0.2%至5.5%)相关。
  • eGFR15-16启动透析较eGFR6-7启动对应全因死亡HR 0.89(95%CI 0.87至0.92)、主要不良心血管事件HR 0.94(95%CI 0.91至0.98)。
  • 模拟IDEAL试验意图策略(eGFR10-14 vs eGFR5-7)全因死亡HR 0.96(95%CI 0.94至0.99),模拟IDEAL实际达到eGFR(eGFR7-10 vs eGFR5-7)HR 0.97(95%CI 0.94至1.00)。

研究设计与关键结果

  • 全国观察性队列研究,纳入10290例晚期慢性肾病患者(中位年龄73岁;3739例(36%)女性;中位eGFR 16.8 mL/min/1.73 m2),其中3822例开始透析、4160例死亡、2446例发生主要不良心血管事件。
  • 死亡风险呈抛物线关系,eGFR15-16启动透析风险最低。
  • eGFR15-16启动透析较eGFR6-7启动,五年绝对死亡风险低5.1%(95%CI 2.5%至6.9%),主要不良心血管事件风险低2.9%(95%CI 0.2%至5.5%),对应HR分别为0.89(95%CI 0.87至0.92)和0.94(95%CI 0.91至0.98)。
  • 5.1%绝对风险差对应五年随访平均推迟死亡1.6个月,但透析需提前四年开始。
  • 模拟IDEAL试验意图策略(eGFR10-14 vs eGFR5-7)全因死亡HR 0.96(95%CI 0.94至0.99),模拟IDEAL实际达到eGFR(eGFR7-10 vs eGFR5-7)HR 0.97(95%CI 0.94至1.00),与随机IDEAL试验结果一致。

证据类型、等级与局限

  • 证据类型:全国观察性队列研究,采用克隆、删失和加权方法模拟临床试验严格设计以消除永恒时间偏倚、领先时间偏倚和幸存者偏倚,使用动态边际结构模型估计调整风险比和绝对风险。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为极早启动透析与死亡率和心血管事件的小幅降低相关;对多数患者,这种降低可能抵不过透析时间显著延长的负担。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To identify the optimal estimated glomerular filtration rate (eGFR) at which to initiate dialysis in people with advanced chronic kidney disease.

DESIGN: Nationwide observational cohort study.

SETTING: National Swedish Renal Registry of patients referred to nephrologists.

PARTICIPANTS: Patients had a baseline eGFR between 10 and 20 mL/min/1.73 m2 and were included between 1 January 2007 and 31 December 2016, with follow-up until 1 June 2017.

MAIN OUTCOME MEASURES: The strict design criteria of a clinical trial were mimicked by using the cloning, censoring, and weighting method to eliminate immortal time bias, lead time bias, and survivor bias. A dynamic marginal structural model was used to estimate adjusted hazard ratios and absolute risks for five year all cause mortality and major adverse cardiovascular events (composite of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) for 15 dialysis initiation strategies with eGFR values between 4 and 19 mL/min/1.73 m2 in increments of 1 mL/min/1.73 m2. An eGFR between 6 and 7 mL/min/1.73 m2 (eGFR6-7) was taken as the reference.

RESULTS: Among 10 290 incident patients with advanced chronic kidney disease (median age 73 years; 3739 (36%) women; median eGFR 16.8 mL/min/1.73 m2), 3822 started dialysis, 4160 died, and 2446 had a major adverse cardiovascular event. A parabolic relation was observed for mortality, with the lowest risk for eGFR15-16. Compared with dialysis initiation at eGFR6-7, initiation at eGFR15-16 was associated with a 5.1% (95% confidence interval 2.5% to 6.9%) lower absolute five year mortality risk and 2.9% (0.2% to 5.5%) lower risk of a major adverse cardiovascular event, corresponding to hazard ratios of 0.89 (95% confidence interval 0.87 to 0.92) and 0.94 (0.91 to 0.98), respectively. This 5.1% absolute risk difference corresponded to a mean postponement of death of 1.6 months over five years of follow-up. However, dialysis would need to be started four years earlier. When emulating the intended strategies of the Initiating Dialysis Early and Late (IDEAL) trial (eGFR10-14 v eGFR5-7) and the achieved eGFRs in IDEAL (eGFR7-10 v eGFR5-7), hazard ratios for all cause mortality were 0.96 (0.94 to 0.99) and 0.97 (0.94 to 1.00), respectively, which are congruent with the findings of the randomised IDEAL trial.

CONCLUSIONS: Very early initiation of dialysis was associated with a modest reduction in mortality and cardiovascular events. For most patients, such a reduction may not outweigh the burden of a substantially longer period spent on dialysis.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Fu EL, Evans M, Carrero JJ, et al. Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study. BMJ. 2021. PMID: 34844936. doi:10.1136/bmj-2021-066306

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。